We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.16K | ﹤0.01% |
47
+21
| +81% | +$1.42K |
2021 Q3
11 quarters
|
|
2652
TriMas Corp
TRS
$1.41B
| $3.14K | ﹤0.01% |
+123
| New | +$3.23K |
2024 Q2
0 quarters
|
|
2653
DELISTED
Flushing Financial
FFIC
| $3.14K | ﹤0.01% |
239
-411
| -63% | -$5.01K |
2023 Q1
5 quarters
|
|
2654
Travere Therapeutics
TVTX
$4.69B
| $3.14K | ﹤0.01% |
382
+95
| +33% | +$640 |
2023 Q4
2 quarters
|
|
2655
ProShares Ultra Consumer Staples
UGE
$9.74M
| $3.14K | ﹤0.01% |
+179
| New | +$3.11K |
2024 Q2
0 quarters
|
|
2656
MKS Inc
MKSI
$14.7B
| $3.13K | ﹤0.01% |
24
+5
| +26% | +$631 |
2019 Q4
18 quarters
|
|
2657
Veeco
VECO
$2.64B
| $3.13K | ﹤0.01% |
67
+49
| +272% | +$1.94K |
2023 Q2
4 quarters
|
|
2658
Replimune Group
REPL
$1.05B
| $3.1K | ﹤0.01% |
+344
| New | +$2.4K |
2024 Q2
0 quarters
|
|
2659
ServisFirst Bancshares
SFBS
$4.32B
| $3.1K | ﹤0.01% |
98
+2
| +2% | +$62 |
2021 Q2
12 quarters
|
|
2660
DELISTED
Assertio
ASRT
| $3.1K | ﹤0.01% |
166
| – | – |
2023 Q3
3 quarters
|
|
2661
BlueLinx
BXC
$573M
| $3.07K | ﹤0.01% |
33
| – | – |
2023 Q3
3 quarters
|
|
2662
OSI Systems
OSIS
$3.1B
| $3.02K | ﹤0.01% |
22
| – | – |
2023 Q1
5 quarters
|
|
2663
XPLR Infrastructure LP
XIFR
$935M
| $3.02K | ﹤0.01% |
109
-689
| -86% | -$20.9K |
2021 Q4
10 quarters
|
|
2664
LivaNova
LIVN
$4.29B
| $3.02K | ﹤0.01% |
55
+13
| +31% | +$741 |
2021 Q3
11 quarters
|
|
2665
Filana Therapeutics
FLNA
$34.2M
| $3.01K | ﹤0.01% |
244
-10
| -4% | -$211 |
2021 Q1
13 quarters
|
|
2666
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.04B
| $2.99K | ﹤0.01% |
261
| – | – |
2022 Q2
8 quarters
|
|
2667
Mercantile Bank Corp
MBWM
$1.02B
| $2.96K | ﹤0.01% |
73
-8
| -10% | -$300 |
2024 Q1
1 quarter
|
|
2668
Perella Weinberg Partners
PWP
$1.01B
| $2.96K | ﹤0.01% |
182
| – | – |
2023 Q1
5 quarters
|
|
2669
Avista
AVA
$3.08B
| $2.94K | ﹤0.01% |
85
| – | – |
2023 Q4
2 quarters
|
|
2670
Newmark Group
NMRK
$2.13B
| $2.94K | ﹤0.01% |
287
| – | – |
2019 Q4
18 quarters
|
|
2671
Stock Yards Bancorp
SYBT
$2.38B
| $2.93K | ﹤0.01% |
59
-361
| -86% | -$16.8K |
2020 Q4
14 quarters
|
|
2672
Five Point Holdings
FPH
$313M
| $2.93K | ﹤0.01% |
1,000
| – | – |
2023 Q1
5 quarters
|
|
2673
InMode
INMD
$816M
| $2.92K | ﹤0.01% |
160
| – | – |
2022 Q2
8 quarters
|
|
2674
Global E Online
GLBE
$6.52B
| $2.9K | ﹤0.01% |
80
| – | – |
2023 Q3
3 quarters
|
|
2675
Crescent Energy
CRGY
$5.62B
| $2.87K | ﹤0.01% |
242
| – | – |
2023 Q1
5 quarters
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.